Abstract
Free full text
The cornea has “the nerve” to encourage immune rejection
‘Supersystem’ is a designation given to a highly integrated life system, which was coined by the late Tomio Tada nearly a decade ago to describe both immune and nervous systems [1]. Even decades earlier, however, were scientists already appreciating the level of interplay that exists between these two supersystems. Work by Paunicka et al now highlight the importance of this relationship in corneal allograft rejection.
The cornea is a fascinating model site to explore how the nervous and immune systems interface, as it is arguably the most densely innervated site in mammals. Furthermore, the cornea enjoys immune privilege status, which is a feature that permits spontaneous acceptance in approximately 50% of corneal allografts in certain mouse strain combinations [2]. Paunicka et al now show that the severing of corneal nerves in the graft bed, an unavoidable consequence of penetrating keratoplasty, abolishes immune privilege that would otherwise be enjoyed by subsequent allografts, even in the fellow eye. This perhaps explains why a markedly increased incidence of failure of second grafts is seen in the clinic.
The authors came to this conclusion with elegant experimentation. They initially found that placement of an allograft led to the increased tempo and incidence of rejection to a subsequently placed corneal allograft in the same, or fellow eye. Importantly, this pattern was not due to a second-set rejection, as the same result was observed when the subsequent allograft was unrelated to the first. However, this antigen nonspecific increase in rejection was indeed T cell mediated, as subsequent syngeneic grafts survived indefinitely. The root cause of increased rejection turned out to be the nerve injury response, originating from the first transplantation. The same results were recapitulated by simply severing of nerves 360 degrees around the cornea. Remarkably, an allograft placed 60 days after such injury also succumbed to increased immune rejection. Authors conclusively demonstrated that a burst of the neuropeptide substance P, produced as an effect of such nerve severing, caused this heightened state of rejection. Furthermore, they show that substance P disables T regulatory (Treg) suppression, and associated this impairment with increased rejection.
How could Tregs be impaired and augment immune rejection to a substance P burst that occurred 60 days prior? The authors are unsure, particularly given a serum half-life of only several minutes. Perhaps one could point to a role for tissue resident macrophages as a possible explanation. Indeed, these mononuclear phagocytes have a long life span of many months to even a year. Furthermore, macrophages express substance P receptors, produce substance P, and are altered by ligation of this neuropeptide [3]. Additionally, macrophages are antigen-presenting cells and can migrate to lymphoid organs, likely in a CCR7 mediated fashion [4]. Importantly, it has been long appreciated that many macrophages reside in close proximity to peripheral nerves [5], consistent in the cornea as well [6]. One can appreciate this in Figure 1, which is an unpublished micrograph generated by our lab demonstrating the proximity of a mononuclear phagocyte with up to 10 distinct nerves in the corneal epithelium. Perhaps one plausible hypothesis to explain the fascinating findings by Paunicka et al is that the unilateral severing of corneal nerves that causes a bilateral substance P burst has a pathogenic imprinting effect on such long-lived macrophages residing proximal to nerves. Thus, upon transplantation, either immediately or long after the substance P burst, perhaps this imprint licenses macrophages to produce additional substance P. If these antigen-presenting cells, laden with alloantigen, could migrate to the lymphoid organ, their substance P may therefore subvert Treg activity and in turn may lead to increased immune rejection.
Irrespective of how substance P produces such a long-lasting ability to augment immune rejection, Paunicka et al forces transplantation immunologists, particularly those studying the cornea, to now consider the interplay of both supersystems as yet another piece of the perplexing puzzle that is immune rejection.
Acknowledgments
Funded by:
R01EY021798 (Saban)
Research to Prevent Blindness, Career Development Award (Saban)
WORKS CITED
Full text links
Read article at publisher's site: https://doi.org/10.1111/ajt.13238
Read article for free, from open access legal sources, via Unpaywall: http://www.amjtransplant.org/article/S160061352227052X/pdf
Citations & impact
Impact metrics
Article citations
The Role of Immune Cells and Signaling Pathways in Diabetic Eye Disease: A Comprehensive Review.
Biomedicines, 12(10):2346, 15 Oct 2024
Cited by: 0 articles | PMID: 39457658 | PMCID: PMC11505591
Review Free full text in Europe PMC
Acquired immunostimulatory phenotype of migratory CD103+ DCs promotes alloimmunity following corneal transplantation.
JCI Insight, 9(20):e182469, 22 Oct 2024
Cited by: 0 articles | PMID: 39235864 | PMCID: PMC11530131
Effects of Diabetes Mellitus on Corneal Immune Cell Activation and the Development of Keratopathy.
Cells, 13(6):532, 18 Mar 2024
Cited by: 1 article | PMID: 38534376 | PMCID: PMC10969384
The miR-183/96/182 cluster regulates sensory innervation, resident myeloid cells and functions of the cornea through cell type-specific target genes.
Sci Rep, 14(1):7676, 01 Apr 2024
Cited by: 0 articles | PMID: 38561433 | PMCID: PMC10985120
Ocular surface parameter changes in the untreated fellow eye after unilateral cataract surgery with short-term administration of anti-inflammatory eye drops.
Sci Rep, 14(1):1080, 11 Jan 2024
Cited by: 1 article | PMID: 38212520 | PMCID: PMC10784480
Go to all (9) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Severing corneal nerves in one eye induces sympathetic loss of immune privilege and promotes rejection of future corneal allografts placed in either eye.
Am J Transplant, 15(6):1490-1501, 14 Apr 2015
Cited by: 46 articles | PMID: 25872977 | PMCID: PMC4590984
Graft failure IV. Immunologic mechanisms of corneal transplant rejection.
Int Ophthalmol, 28(3):209-222, 01 Jun 2008
Cited by: 60 articles | PMID: 17673946
Review
The taming of the shrew? The immunology of corneal transplantation.
Acta Ophthalmol, 87(5):488-497, 01 Aug 2009
Cited by: 22 articles | PMID: 19664109
Review
Corneal allograft rejection: current understanding. I. Immunobiology and basic mechanisms.
Ophthalmologica, 215(4):254-262, 01 Jul 2001
Cited by: 13 articles | PMID: 11399931
Review
Funding
Funders who supported this work.
NEI NIH HHS (2)
Grant ID: R01 EY021798
Grant ID: R01EY021798
Research to Prevent Blindness (1)
Grant ID: R01EY021798